Drug Profile
HIV vaccine - United Biomedical
Alternative Names: HIV synthetic peptide vaccine - United Biomedical; p2249fLatest Information Update: 28 Sep 2018
Price :
$50
*
At a glance
- Originator United Biomedical
- Developer Nonindustrial source; United Biomedical
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for preclinical development in HIV-infections in USA (Parenteral, Injection)
- 23 Sep 2016 Preclinical development is ongoing in USA (United Biomedical pipeline, September 2016)
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in USA (Parenteral, Injection)